1) Understanding the interface between gut microbiome-gastrointestinal cancers
Non-invasive detection of gastrointestinal cancers through the assessment of the oral microbiota
Pretreatment patients stratification to predict treatment response or long-term prognosis
Multiomics-based identification of cancer-associated microbial pathways
Prevotella: an 'oriental' species that may hold a secret for treating colorectal cancer
Fungal community analysis in inflammatory bowel disease (IBD) and healthy individuals
Inter-kingdom correlation in IBD
Gut microbiota assoicated with exercise performannce
Ameliorating systemic inflammations and other clinical features
Diet-induced changes in microbiome
Oral-to-gut microbial transmission and its implications in host conditions
HIV treatment prognosis and relevant microbial signatures
Developing a breakthrough to remove spurious correlations